Table 2.
Projections of Total Cost of Care ($ Billions) for HF for Different Age Groups of the US Population*
| Year | All | 18–44 y | 45–64 y | 65–79 y | ≥80 y |
|---|---|---|---|---|---|
| 2012 | |||||
| Medical | 20.9 | 0.33 | 3.67 | 8.46 | 8.42 |
| Indirect: Morbidity | 5.42 | 0.52 | 1.92 | 2.05 | 0.93 |
| Indirect: Mortality | 4.35 | 0.66 | 2.53 | 0.98 | 0.18 |
| Total | 30.7 | 1.51 | 8.12 | 11.5 | 9.53 |
| 2020 | |||||
| Medical | 31.1 | 0.43 | 4.58 | 14.2 | 11.8 |
| Indirect: Morbidity | 7.09 | 0.66 | 2.20 | 3.11 | 1.12 |
| Indirect: Mortality | 5.39 | 0.79 | 2.89 | 1.49 | 0.22 |
| Total | 43.6 | 1.88 | 9.67 | 18.8 | 13.2 |
| 2030 | |||||
| Medical | 53.1 | 0.59 | 5.86 | 23.3 | 23.4 |
| Indirect: Morbidity | 9.80 | 0.91 | 2.54 | 4.48 | 1.87 |
| Indirect: Mortality | 6.84 | 0.98 | 3.32 | 2.16 | 0.37 |
| Total | 69.7 | 2.48 | 11.7 | 29.9 | 25.6 |
HF indicates heart failure.
*
Excludes HF care costs that have been attributed to comorbid conditions.